Nova Patents
ES2962852T3

Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof

Abstract

Disclosed herein are compounds that are inhibitors of autophagy and their use in the treatment of disorders such as cancers. (Automatic translation with Google Translate, without legal value)

Term

13.6 yearsto projected expiry

Projected expiry 8 May 2040, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

53 members in 30 offices

This recordMember, by publication datePriority claim20 more offices are in the list below

Priority claims9

Priority claims
DocumentOfficeKindDate
201962846260PUnited States of America–
201962846264PUnited States of America–
201962846260United States of AmericaP
201962846264United States of AmericaP
201962911733PUnited States of America–
201962911736PUnited States of America–
201962911733United States of AmericaP
201962911736United States of AmericaP
2020032090United States of AmericaW

Members53

Family members, oldest first
DocumentOfficeKind
US2020354346A1United States of AmericaA1
CA3139120A1CanadaA1
WO2020231808A1World Intellectual Property Organization (WIPO)A1
TW202108574ATaiwan Province of ChinaA
AU2020274011A1AustraliaA1
SG11202112171XASingaporeA
IL287795AIsraelA
IL287795D0IsraelD0
BR112021022576A2BrazilA2
KR20220019696ARepublic of KoreaA
CN114072397AChinaA
MX2021013662AMexicoA
MX2021013662AMexicoA
EP3966206A1European Patent Office (EPO)A1
MA55888AMoroccoA
MA55888AMoroccoA
CO2021016765A2ColombiaA2
PE20220592A1PeruA1
JP2022531932AJapanA
CL2021002953A1ChileA1
US11390611B2United States of AmericaB2
AR122264A1ArgentinaA1
US11518758B2United States of AmericaB2
PH12021552856A1PhilippinesA1
US2023047915A1United States of AmericaA1
EP3966206B1European Patent Office (EPO)B1
FI3966206T3FinlandT3
LT3966206TLithuaniaT
PT3966206TPortugalT
DK3966206T3DenmarkT3
SMT202300364T1San MarinoT1
MA55888B1MoroccoB1
RS64755B1SerbiaB1
EP4295846A2European Patent Office (EPO)A2
SI3966206T1SloveniaT1
PL3966206T3PolandT3
HRP20231310T1CroatiaT1
AU2020274011B2AustraliaB2
EP4295846A3European Patent Office (EPO)A3
ES2962852T3This recordSpainT3
HUE064465T2HungaryT2
AU2024203193A1AustraliaA1
IL287795B1IsraelB1
IL317676AIsraelA
CN114072397BChinaB
IL287795B2IsraelB2
JP7678763B2JapanB2
TWI888380BTaiwan Province of ChinaB
CN120247875AChinaA
JP2025118762AJapanA
TW202544009ATaiwan Province of ChinaA
US12479833B2United States of AmericaB2
US20260042750A1United States of AmericaA1